Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation

Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/31752
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC-BY-NC-ND 4.0)
Coleccións
- Investigación (FCS) [1295]
Metadatos
Mostrar o rexistro completo do ítemTítulo
Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activationAutor(es)
Data
2022-05-18Cita bibliográfica
Val-Blasco A, Prieto P, Jaén RI, Gil-Fernández M, Pajares M, Domenech N, Terrón V, Tamayo M, Jorge I, Vázquez J, Bueno-Sen A, Vallejo-Cremades MT, Pombo-Otero J, Sanchez-García S, Ruiz-Hurtado G, Gómez AM, Zaragoza C, Crespo-Leiro MG, López-Collazo E, Cuadrado A, Delgado C, Boscá L, Fernández-Velasco M. Specialized proresolving mediators protect against experimental autoimmune myocarditis by modulating Ca2+ handling and NRF2 activation. JACC Basic Transl Sci. 2022 May 18;7(6):544-560.
Resumo
[Abstract] Specialized proresolving mediators and, in particular, 5(S), (6)R, 7-trihydroxyheptanoic acid methyl ester (BML-111) emerge as new therapeutic tools to prevent cardiac dysfunction and deleterious cardiac damage associated with myocarditis progression. The cardioprotective role of BML-111 is mainly caused by the prevention of increased oxidative stress and nuclear factor erythroid-derived 2-like 2 (NRF2) down-regulation induced by myocarditis. At the molecular level, BML-111 activates NRF2 signaling, which prevents sarcoplasmic reticulum–adenosine triphosphatase 2A down-regulation and Ca2+ mishandling, and attenuates the cardiac dysfunction and tissue damage induced by myocarditis.
Palabras chave
Calcium handling
Myocarditis
NRF2
Pro-resolving mediators
SERCA2A
Myocarditis
NRF2
Pro-resolving mediators
SERCA2A
Descrición
Preclinical research
Versión do editor
Dereitos
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC-BY-NC-ND 4.0)
ISSN
2452-302X
Ítems relacionados
Mostrando ítems relacionados por Título, autor ou materia.
-
Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry
Barriales-Villa, Roberto; Ochoa, Juan Pablo; Larrañaga Moreira, José María; Salazar-Mendiguchía, Joel; Díez-López, Carles; Restrepo-Córdoba, María Alejandra; Álvarez-Rubio, Jorge; Robles-Mezcua, Ainhoa; Olmo-Conesa, María C.; Nicolás-Rocamora, Elisa; Sanz, Jorge; Villacorta, Eduardo; Gallego-Delgado, María; Yotti, Raquel; Espinosa, María Ángeles; Manovel, Ana; Rincón-Díaz, Luis M.; Jiménez-Jáimez, Juan; Bermúdez-Jiménez, Francisco J.; Basurte-Elorz, M. Teresa; Climent-Payá, Vicente; García-Álvarez, María I.; Rodríguez-Palomares, José Fernando; Limeres-Freire, Javier; Pérez-Guerrero, Ainhoa; Cantero-Pérez, Eva M.; Peña-Peña, María Luisa; Palomino-Doza, Julián; Crespo-Leiro, María Generosa; García-Pinilla, José Manuel; Zorio, Esther; Ripoll-Vera, Tomás; García-Pavía, Pablo; Ortiz-Genga, Martín; Monserrat, Lorenzo (Elsevier, 2020-06-29)[Abstract] Introduction and objectives. According to sudden cardiac death guidelines, an implantable cardioverter-defibrillator (ICD) should be considered in patients with LMNA-related dilated cardiomyopathy (DCM) and ... -
Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus: IMMINENT study
Ramos-Araque, María E.; Castellanos, María del Mar; Naya Rios, Lucía; López-Cancio Martínez, Elena; Molina-Gil, Javier; Marta Moreno, Javier; Tejada Meza, Herbert; Temprano-Fernández, María Teresa; Antón-González, Celia; Vidal-de Francisco, Diana; Tejada García, Javier; Maciñeiras Montero, José Luis; Vicente Alba, Pablo; García-Sánchez, Juan Manuel; Aguilera-Irazabal, Borja; Martínez-Zabaleta, Maite; Díez, I.N.; Pinedo Brochado, Ana; Azcune-Calle, Itxaso; Freijo Guerrero, María del Mar; Moreno-Estebanez, A.; Palacio-Portilla, Enrique Jesús; Manrique Arregui, L.; Rodríguez-Yáñez, Manuel; Santamaría Cadavid, María; Timiraos, Juan; Herrero-Infante, Yolanda; Trejo-Gabriel-Galán, José María; Echavarría-Iñiguez, Ana; Tejero Juste, Carlos; Rodríguez-Montolio, Joana; Julián Villaverde, Francisco; Moreno García, María Pilar; López-Mesonero, Luis; Redondo-Robles, Laura; Aymerich, Nuria; Korroza, J.; Arenillas, Juan (Elsevier, 2024-07-03)[Abstract] Background. Our primary aim was to investigate the incidence of non-cardioembolic minor acute ischemic stroke (AIS) and high-risk transient ischemic attack (TIA) and to identify predictors of stroke recurrence/death ... -
Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry
Ramos-Araque, María E.; Chavarría-Miranda, Alba; Gómez-Vicente, Beatriz; López-Cancio Martínez, Elena; Castañón Apilánez, María; Castellanos, María del Mar; López Fernández, María; Tejada Meza, Herbert; Marta Moreno, Javier; Tejada García, Javier; Beltrán Rodríguez, Iria; de la Riva, Patricia; Díez, Noemí; Arias Rivas, Susana; Santamaría Cadavid, María; Bravo Anguiano, Yolanda; Bártulos Iglesias, Mónica; Palacio-Portilla, Enrique Jesús; Revilla García, Marian; Timiraos, Juan; Arenaza Basterrechea, Naroa; Maciñeiras Montero, José Luis; Vicente Alba, Pablo; Julián Villaverde, Francisco; Pinedo Brochado, Ana; Azkune, Itxaso; Freijo Guerrero, María del Mar; Luna, Alain; Arenillas, Juan (Frontiers, 2020-11-26)[Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ...